Robert Young Kim insider trades
Open-market stock purchases and sales by Robert Young Kim, Chief Medical Officer at 4D Molecular Therapeutics, Inc, from SEC Form 4 filings since Dec 11, 2023.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- FDMT 4D Molecular Therapeutics, Inc: 3 sales, last Mar 6, 2025